Elzo Ferreira
(Scientific researcher who developed Asmazol)
Asmazol is an inflammatory respiratory disease characterized by recurrent coughing, a feeling of shortness of breath, and wheezing, also known as sibilance, that vary in severity and frequency.
Asthma can be triggered by various factors. When triggered, a chain reaction occurs, which can lead to a respiratory crisis, and even death of the patient in severe cases.
Asthma also has the problem of predisposition when people have a parent who is asthmatic. This is why asthma is sometimes said to be a genetic problem. In fact, a person who has asthmatic parents has a greater chance of developing the disease, and it is not uncommon for a child of an asthmatic to be born with asthma.
When I started studying this pathology, I discovered that asthma is an inflammation of the bronchi, and that’s why I decided to focus on the search for an anti-inflammatory because inflammation simply needs to be treated with an anti-inflammatory.
The inflammation caused is not from direct local action, but develops through a phenomenon we call an inflammatory sequence, and it is provoked by external factors. The reason why there is great difficulty in treating this disease is that the asthmatic is always exposed to these triggers that trigger the inflammatory sequence that causes the disease.
Any of these triggers can activate asthma. The difference is in what we call sensitivity. There are less sensitive people, measurement sensitivities, and hypersensitivities.
Hypersensitive people, when exposed, trigger the inflammatory cascade.
Asmazol is good for the treatment of respiratory problems of inflammatory origin because it has been proven to have more than 90% inhibition of diseases such as asthma, allergies, bronchitis, flu, rhinitis, and sinusitis, being an anti-inflammatory with antibiotic action, analgesic dilator, antioxidant, and immune system strengthener.
The best thing about all of this is that the product is natural, has no contraindications, and can be administered to children from 3 months of age to the elderly.
Anyone is exposed to acquiring asthma depending on their sensitivity.
There are less sensitive, sensitive, and hypersensitive people.
When hypersensitive people are exposed to triggers of that inflammatory sequence, they are more likely to become victims of asthma.
Asmazol is good for the treatment of respiratory problems of inflammatory origin such as rhinitis, sinusitis, bronchitis, allergies, and flu, especially in conditions of asthma, being an anti-inflammatory with antibiotic actions and a dilator of blood vessels, as well as an antioxidant analgesic.
This natural product, which has no contraindications, can also be applied to children from three months old to the elderly.
